Boston Therapeutics, Inc.
USD0.01
+0.00 (+0.00%)
CEO
Chi-Heng Cheng
IPO Date
2012-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.07
Volume
0.11M
| -0.3 |
| 31 Dec 2018 | FY | -111.6% | -11352.1% | 86.9% | -250.2% | -0.68 | 0.20 | -0.3 |
| 31 Dec 2017 | FY | 100.0% | -5398.8% | 40.8% | -175.4% | -0.64 | 0.11 | -0.3 |
| 31 Dec 2016 | FY | 4.8% | -3779.9% | 119.8% | -266.0% | -0.45 | 0.77 | -0.1 |
| 31 Dec 2015 | FY | -143.0% | -2516.5% | 469.3% | -283.6% | -0.74 | 0.22 | -0.2 |
| 31 Dec 2014 | FY | 11.9% | -2354.9% | -6294.9% | -404.1% | 3.99 | 0.56 | -0.1 |
| 31 Dec 2013 | FY | 14.0% | -1422.8% | -137.6% | -101.5% | 0.00 | 4.21 | -0.1 |
| 31 Dec 2012 | FY | -34.6% | -3512.4% | -213.1% | -103.4% | 0.00 | 1.35 | -0.1 |
| 31 Dec 2011 | FY | -55.0% | -20116.0% | -194.8% | -71.9% | 0.00 | 0.55 | -0.2 |
| -0.6 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | 354.1% | -27802.5% | -0.29 | 0.02 | -0.1 |
| 31 Dec 2020 | Q4 | -1434.8% | -32663.7% | 4.1% | -1787.5% | -0.56 | 0.00 | -0.8 |
| 30 Sept 2020 | Q3 | -149.9% | -8522.5% | 2.3% | -132.4% | -0.58 | 0.02 | -1.5 |
| 30 Jun 2020 | Q2 | -66.3% | -8065.0% | 2.9% | -280.4% | -0.57 | 0.01 | -1.2 |
| 31 Mar 2020 | Q1 | -58.5% | -4085.4% | 1.6% | -209.4% | -0.55 | 0.01 | -2.2 |
| 31 Dec 2019 | Q4 | -105.7% | -67096.1% | 28.1% | -9070.9% | -0.53 | 0.00 | -0.1 |
| 30 Sept 2019 | Q3 | -107.4% | -8295.2% | 5.4% | -40.9% | -0.66 | 0.05 | -0.9 |
| 30 Jun 2019 | Q2 | -9.8% | -5243.4% | 5.3% | -34.3% | -0.62 | 0.07 | -1.0 |